Sarepta Therapeutics (SRPT) PT Lowered to $185 at Piper Jaffray
Tweet
Share
E-mail
Get Alerts SRPT Hot Sheet
Price: $18.78 -4.82%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 20
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 20
Join SI Premium – FREE
Piper Jaffray analyst Danielle Brill lowered the price target on Sarepta Therapeutics (NASDAQ: SRPT) to $185.00 (from $208.00) while maintaining a Overweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- HCA Healthcare Inc (HCA) PT Lowered to $425 at JPMorgan
- Estee Lauder (EL) PT Raised to $112 at JPMorgan
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Piper JaffraySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
